The Japanese Heart Failure Society set a cut-off point of 35 pg/mL for plasma BNP to identify patients with mild heart failure and a cut-off of 100 pg/mL to identify patients with heart failure requiring medication (Preventive Committee for Japanese Heart Failure Society, 2023). This evidence concerns the gene NPPB and heart failure.